Search details
1.
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.
N Engl J Med
; 389(26): 2436-2445, 2023 Dec 28.
Article
in English
| MEDLINE | ID: mdl-37921461
2.
Rationale and design of the Nephrotic Syndrome Study Network (NEPTUNE) Match in glomerular diseases: designing the right trial for the right patient, today.
Kidney Int
; 105(2): 218-230, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38245210
3.
De novo TRIM8 variants impair its protein localization to nuclear bodies and cause developmental delay, epilepsy, and focal segmental glomerulosclerosis.
Am J Hum Genet
; 108(2): 357-367, 2021 02 04.
Article
in English
| MEDLINE | ID: mdl-33508234
4.
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.
Lancet
; 401(10388): 1584-1594, 2023 05 13.
Article
in English
| MEDLINE | ID: mdl-37015244
5.
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Lancet
; 402(10417): 2077-2090, 2023 12 02.
Article
in English
| MEDLINE | ID: mdl-37931634
6.
Pediatric contributions and lessons learned from the NEPTUNE cohort study.
Pediatr Nephrol
; 2024 Jan 18.
Article
in English
| MEDLINE | ID: mdl-38233720
7.
Growth in children with nephrotic syndrome: a post hoc analysis of the NEPTUNE study.
Pediatr Nephrol
; 2024 Apr 26.
Article
in English
| MEDLINE | ID: mdl-38671228
8.
Longitudinal analysis of blood pressure and lipids in childhood nephrotic syndrome.
Pediatr Nephrol
; 39(7): 2161-2170, 2024 Jul.
Article
in English
| MEDLINE | ID: mdl-38319465
9.
The association of low birthweight and prematurity on outcomes in children and adults with nephrotic syndrome-a NEPTUNE cohort study.
Pediatr Nephrol
; 38(10): 3297-3308, 2023 10.
Article
in English
| MEDLINE | ID: mdl-37140708
10.
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome.
Pediatr Nephrol
; 38(3): 877-919, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36269406
11.
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis. Reply.
N Engl J Med
; 390(12): 1154-1155, 2024 Mar 21.
Article
in English
| MEDLINE | ID: mdl-38507769
12.
Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.
Am J Kidney Dis
; 79(4): 570-581, 2022 04.
Article
in English
| MEDLINE | ID: mdl-34571062
13.
Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan.
Am J Nephrol
; 53(10): 675-686, 2022.
Article
in English
| MEDLINE | ID: mdl-36404708
14.
Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies.
Am J Nephrol
; 53(10): 687-700, 2022.
Article
in English
| MEDLINE | ID: mdl-36423588
15.
Determinants of medication adherence in childhood nephrotic syndrome and associations of adherence with clinical outcomes.
Pediatr Nephrol
; 37(7): 1585-1595, 2022 07.
Article
in English
| MEDLINE | ID: mdl-34796395
16.
Natural antibody and complement activation characterize patients with idiopathic nephrotic syndrome.
Am J Physiol Renal Physiol
; 321(4): F505-F516, 2021 10 01.
Article
in English
| MEDLINE | ID: mdl-34459222
17.
Proteinuria Reduction and Kidney Survival in Focal Segmental Glomerulosclerosis.
Am J Kidney Dis
; 77(2): 216-225, 2021 02.
Article
in English
| MEDLINE | ID: mdl-32791086
18.
APOL1 genotype-associated morphologic changes among patients with focal segmental glomerulosclerosis.
Pediatr Nephrol
; 36(9): 2747-2757, 2021 09.
Article
in English
| MEDLINE | ID: mdl-33646395
19.
Serially assessed bisphenol A and phthalate exposure and association with kidney function in children with chronic kidney disease in the US and Canada: A longitudinal cohort study.
PLoS Med
; 17(10): e1003384, 2020 10.
Article
in English
| MEDLINE | ID: mdl-33052911
20.
An international cohort study of autosomal dominant tubulointerstitial kidney disease due to REN mutations identifies distinct clinical subtypes.
Kidney Int
; 98(6): 1589-1604, 2020 12.
Article
in English
| MEDLINE | ID: mdl-32750457